**Author details**

Gianmarco Mangiaterra\*, Mehdi Amiri, Nicholas Cedraro and Francesca Biavasco Department of Life and Environmental Sciences, Polytechnic University of Marche, Ancona, Italy

\*Address all correspondence to: g.mangiaterra@pm.univpm.it

© 2021 The Author(s). Licensee IntechOpen. This chapter is distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/ by/3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

**47**

*Pseudomonas aeruginosa* Biofilm Lung Infection in Cystic Fibrosis: The Challenge of Persisters

bacteria. FEMS Microbiol Rev. 2017; 41: 276-301. DOI: 10.1093/femsre/fux010.

[9] Azimi S, Klementiev AD, Whiteley M, Diggle SP: Bacterial Quorum Sensing During Infection. Annu Rev Microbiol. 2020; 74: 201-219. DOI: 10.1146/ annurev-micro-032020-093845.

[10] Moradali MF, Ghods S, Rehm BHA: *Pseudomonas aeruginosa* Lifestyle: A Paradigm for Adaptation, Survival, and Persistence. Front Cell Infect Microbiol. 2017; 7: 39. DOI: 10.3389/

[11] Olsen I: Biofilm-specific antibiotic tolerance and resistance. Eur J Clin Microbiol Infect Dis. 2015; 34: 877-886. DOI: 10.1007/s10096-015-2323-z.

[12] Flemming HC and Wingender J: The biofilm matrix. Nat Rev Microbiol. 2010; 8: 623-633. DOI: 10.1038/nrmicro2415.

[13] Valentini M, Gonzalez D, Mavridou DA, Filloux A: Lifestyle transitions and adaptive pathogenesis of *Pseudomonas aeruginosa*. Curr Opin Microbiol. 2018; 41:15-20. DOI:

10.1016/j.mib.2017.11.006.

fmicb.2019.00570.

10.4014/jmb.1611.11056.

[14] Rojo-Molinero E, Macià MD, Oliver A. Social Behavior of Antibiotic Resistant Mutants Within *Pseudomonas aeruginosa* Biofilm Communities. Front Microbiol. 2019; 10: 570. DOI: 10.3389/

[15] Lee K and Yoon SS: *Pseudomonas aeruginosa* Biofilm, a Programmed Bacterial Life for Fitness. J Microbiol Biotechnol. 2017; 27: 1053-1064. DOI:

[16] Brencic A and Lory S: Determination of the regulon and identification of novel mRNA targets of *Pseudomonas aeruginosa* RsmA. Mol Microbiol. 2009; 72: 612-632. DOI: 10.1111/j.1365-2958.2009.06670.x.

fcimb.2017.00039.

*DOI: http://dx.doi.org/10.5772/intechopen.95590*

[1] Costerton JW, Stewart PS, Greenberg EP: Bacterial biofilms: a common cause of persistent infections. Science. 1999; 284: 1318-22. DOI: 10.1126/

[2] Ayrapetyan M, Williams T, Oliver JD: Relationship between the Viable but Nonculturable State and Antibiotic Persister Cells. J Bacteriol. 2018; 200: e00249-18. DOI: 10.1128/JB.00249-18.

[3] Wood TK, Song S, Yamasaki R: Ribosome dependence of persister cell formation and resuscitation. J Microbiol. 2019; 57: 213-219. DOI: 10.1007/s12275-019-8629-2.

[4] Stewart PS and Bjarnsholt T: Risk factors for chronic biofilm-related infection associated with implanted medical devices. Clin Microbiol Infect. 2020; 26: 1034-1038. DOI: 10.1016/j.

[5] Pasquaroli S, Zandri G, Vignaroli C, Vuotto C, Donelli G, Biavasco F: Antibiotic pressure can induce the viable but non-culturable state in *Staphylococcus aureus* growing in

biofilms. J Antimicrob Chemother. 2013; 68: 1812-1817. DOI: 10.1093/jac/dkt086.

Cirilli N, Citterio B, Vignaroli C, Biavasco

[6] Mangiaterra G, Amiri M, Di Cesare A, Pasquaroli S, Manso E,

F: Detection of viable but nonculturable *Pseudomonas aeruginosa* in cystic fibrosis by qPCR: a validation study. BMC Infect Dis. 2018; 18: 701. DOI: 10.1186/s12879-018-3612-9.

[7] Donlan RM and Costerton JW: Biofilms: survival mechanisms of clinically relevant microorganisms. Clin Microbiol Rev. 2002; 15: 167-193. DOI:

10.1128/cmr.15.2.167-193.2002.

[8] Hall CW and Mah TF: Molecular mechanisms of biofilm-based antibiotic resistance and tolerance in pathogenic

cmi.2020.02.027.

**References**

science.284.5418.1318.

*Pseudomonas aeruginosa* Biofilm Lung Infection in Cystic Fibrosis: The Challenge of Persisters *DOI: http://dx.doi.org/10.5772/intechopen.95590*
